Progressive resistance training with or at risk for breast-cancer-related lymphedema

MS-N132 · Supportive care · Human evidence · Appraised 25 October 2026

Does slowly progressive weight training worsen—or safely support recovery in—people with or at risk for breast-cancer-related arm lymphedema?

Evidence at a glance

Evidence label: Supported when gradual and supervised; it does not replace lymphedema assessment or treatment
Benefit: A large year-long trial found no increase in arm swelling and fewer exacerbations among participants with stable lymphedema; a companion cohort found no increased onset among those at risk.
Certainty: Moderate because randomized evidence is substantial, although participants were selected, trained and monitored in a structured program.
Risk: Musculoskeletal injury and symptom flares can occur; abrupt heavy loading, poor technique or exercising through infection is different from the studied gradual program.

What was studied

Population and design: The PAL program included 295 breast-cancer survivors: 141 with stable arm lymphedema and 154 at risk. Participants were randomized to twice-weekly progressive weight lifting or no weight lifting for 12 months.

Studied regimen: Loads started low, advanced slowly and were taught by trained staff. Participants with lymphedema used their prescribed compression garment during training. The evidence does not test unsupervised maximal lifting immediately after surgery.

What the evidence found

Among 141 participants with stable lymphedema, arm swelling did not increase. Lymphedema exacerbations assessed by a certified specialist occurred in 14% of the weight-lifting group versus 29% of controls; symptoms and strength also improved.

Among 154 participants at risk, progressive lifting did not increase new lymphedema. In the prespecified subgroup with five or more nodes removed, a 5% or greater inter-arm volume increase occurred in 3 of 45 (7%) versus 11 of 49 controls (22%); that subgroup result should not be overgeneralized.

How to interpret it

The practical message is that fear-based avoidance of all upper-body resistance exercise is not supported. Safety depended on slow progression, surveillance and access to lymphedema expertise. The trials were not designed to show that resistance training cures established lymphedema or prevents cancer recurrence.

Practical safety context

Pause and seek assessment for new persistent swelling, heaviness, skin redness, warmth, fever, marked pain or sudden shortness of breath. Cellulitis requires prompt treatment. A certified lymphedema therapist can individualize compression, range of motion and progression after surgery or radiation.

Questions for the care team

Is swelling stable, and has another cause such as clot, infection or recurrence been excluded?
What starting load and progression are appropriate after surgery, radiation and node removal?
Should a fitted compression garment be worn during exercise?

Funding and conflicts

The PAL trial was supported by U.S. public and nonprofit funding. Publication-level author disclosures should be reviewed when making program decisions; the intervention relied on trained supervision rather than a commercial product.

Sources

Last literature search: 25 October 2026. Record appraisal: 25 October 2026. This page is educational and does not replace individualized medical advice. Symptom or function improvement must not be interpreted as evidence of tumor response, delayed recurrence or longer survival.